  | Donis, N., Jiang, Z., D'Emal, C., Hulin, A., Debuisson, M., Dulgheru, R. E., Nguyen, M.-L., Postolache, A., LALLEMAND, F., COUCKE, P., Martinive, P., Herzog, M., Pamart, D., Terrell, J., Pincemail, J., Drion, P., DELVENNE, P., Nchimi Longang, A., LANCELLOTTI, P., & Oury, C. (28 February 2022). Differential Biological Effects of Dietary Lipids and Irradiation on the Aorta, Aortic Valve, and the Mitral Valve. Frontiers in Cardiovascular Medicine, 9, 1-16. doi:10.3389/fcvm.2022.839720  Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LEROI, N., Blacher, S., Bahri, M. A., Balteau, E., COUCKE, P., Noël, A., Plenevaux, A., & Martinive, P. (2021). Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study. Frontiers in Oncology. doi:10.3389/fonc.2021.784437 Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2019). Tumor modifications recorded with IVIM and DCE-MRI after Neoadjuvant radiotherapy. Radiotherapy and Oncology, 133 (Supplement 1), 284 - S285. doi:10.1016/S0167-8140(19)30960-0 Peer Reviewed verified by ORBi |
  | Rolot, M., Dougall, A., Javaux, J., Lallemand, F., Machiels, B., Martinive, P., Gillet, L., & Dewals, B. G. (2019). Recruitment of hepatic macrophages from monocytes is independent of IL-4Ralpha but is associated with ablation of resident macrophages in schistosomiasis. European Journal of Immunology. doi:10.1002/eji.201847796 Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Brain modifications after stereotactic radiotherapy recorded by Functional MRI. Radiotherapy and Oncology, 127 (Supplement 1), 582. doi:10.1016/S0167-8140(18)31346-X Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Tumor microenvironment modifications recorded with IVIM perfusion analysis after radiotherapy. Radiotherapy and Oncology, 127 (Supplement 1), 1285-S1286. doi:10.1016/S0167-8140(18)32640-9 Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., Plenevaux, A., & Martinive, P. (14 March 2018). Evaluation of tumor perfusion with IVIM analysis after radiotherapy [Paper presentation]. Fourth Symposium on small animal precision image-guided radiotherapy, Lisbonne, Portugal. |
 | LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., Plenevaux, A., & Martinive, P. (12 March 2018). Brain stereotactic radiotherapy damages recorded by Functional MRI [Poster presentation]. Fourth Symposium on small animal precision image-guided radiotherapy, Lisbonne, Portugal. |
 | Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., LALLEMAND, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B., Vanderplasschen, A., Lambrecht, B. N., Bureau, F., & Gillet, L. (2018). Correction to: A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes (Nature Immunology, (2017), 18, 12, (1310-1320), 10.1038/ni.3857). Nature Immunology, 19 (9), 1035. doi:10.1038/s41590-017-0024-8 Peer Reviewed verified by ORBi |
 | LOVINFOSSE, P., POLUS, M., VAN DAELE, D., Martinive, P., DAENEN, F., Hatt, M., Visvikis, D., KOOPMANSCH, B., LAMBERT, F., COIMBRA MARQUES, C., SEIDEL, L., Albert, A., Delvenne, P., & Hustinx, R. (2018). FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-017-3855-5 Peer Reviewed verified by ORBi |
 | Vandaele, R., Aceto, J., Muller, M., Peronnet, F., Debat, V., Wang, C.-W., Huang, C.-T., Jodogne, S., Martinive, P., Geurts, P., & Marée, R. (2018). Landmark detection in 2D bioimages for geometric morphometrics: a multi-resolution tree-based approach. Scientific Reports, 8 (1), 538. doi:10.1038/s41598-017-18993-5 Peer Reviewed verified by ORBi |
Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., Lallemand, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B. G., Vanderplasschen, A., Lambrecht, B. N., Bureau, F., & Gillet, L. (December 2017). A gammaherpesviru provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes [Paper presentation]. Belgian Society for Virology. Peer reviewed |
Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., Lallemand, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B. G., Vanderplasschen, A., Lambrecht, B., Bureau, F., & Gillet, L. (October 2017). A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes [Paper presentation]. Farah Day 2017. Peer reviewed |
Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., Lallemand, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B. G., Vanderplasschen, A., Lambrecht, B., Bureau, F., & Gillet, L. (July 2017). A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes [Paper presentation]. International Herpesvirus Workshop. Peer reviewed |
 | LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (May 2017). Following tumour microenvironment after Neoadjuvant radiotherapy with IVIM perfusion analysis. Radiotherapy and Oncology, 123 (Supplement 1), 545. doi:10.1016/S0167-8140(17)31424-X Peer Reviewed verified by ORBi |
Machiels, B., Dourcy, M., Xiao, X., Mesnil, C., Sabatel, C., Desmecht, D., Lallemand, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B. G., Vanderplasschen, A., Lambrecht, B., Bureau, F., & Gillet, L. (May 2017). A gammaherpesvirus infection protects against allergic asthma through the replacement of resident alveolar macrophages by regulatory monocytes [Paper presentation]. Immunology Day - FNRS immunology doctoral school. Peer reviewed |
 | Berkovic, P., GULYBAN, A., Nguyen, P. V., DECHAMBRE, D., Martinive, P., JANSEN, N., Lakosi, F., Janvary, L., & Coucke, P. (20 March 2017). Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence. Clinical Colorectal Cancer, 16 (4), 349-357.e1. doi:10.1016/j.clcc.2017.03.006 Peer Reviewed verified by ORBi |
 | Vandaele, R., LALLEMAND, F., MARTINIVE, P., GULYBAN, A., JODOGNE, S., COUCKE, P., Geurts, P., & Marée, R. (2017). Automated multimodal volume registration based on supervised 3D anatomical landmark detection. In SCITEPRESS Digital Library. Peer reviewed |
 | Goffart, N.* , LOMBARD, A.* , Lallemand, F., Kroonen, J., Nassen, J., Di Valentin, E., Berendsen, S., Dedobbeleer, M., Willems, E., Robe, P., Bours, V., Martin, D., Martinive, P., Maquet, P., & Rogister, B. (2017). CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone. Neuro-Oncology, 19 (1), 66-77. doi:10.1093/neuonc/now136 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | VAN DAELE, D., Honoré, P., COLLIGNON, J., POLUS, M., LOLY, C., MUTIJIMA NZARAMBA, E., De Roover, A., Coucke, P., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localises de l'oesophage. Etat actuel des donnees et strategie therapeutique. 1ere partie : le point sur les approches chirurgicales et non chirurgicales. Revue Médicale de Liège, 72 (2), 58-63. Peer reviewed |
 | Machiels, B., Dourcy, M., Xiao, X., Javaux, J., Mesnil, C., Sabatel, C., Desmecht, D., Lallemand, F., Martinive, P., Hammad, H., Guilliams, M., Dewals, B. G., Vanderplasschen, A., Lambrecht, B. N., Bureau, F., & Gillet, L. (2017). A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes. Nature Immunology. doi:10.1038/ni.3857 Peer Reviewed verified by ORBi |
 | VAN DAELE, D., Honoré, P., COLLIGNON, J., POLUS, M., LOLY, C., MUTIJIMA NZARAMBA, E., De Roover, A., Coucke, P., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localises de l'oesophage. Etat actuel des donnees et strategie therapeutique. 2eme partie : l'interet des approches multimodales avec ou sans chirurgie. Revue Médicale de Liège, 72 (4), 168-174. Peer reviewed |
 | Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483 Peer Reviewed verified by ORBi |
 | Leroi, N., LALLEMAND, F., COUCKE, P., Noël, A., & MARTINIVE, P. (30 March 2016). Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment. Frontiers in Pharmacology, 7, 1-9. doi:10.3389/fphar.2016.00078 Peer Reviewed verified by ORBi |
 | LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., Plenevaux, A., & MARTINIVE, P. (22 March 2016). Feasibility study of repetitive diffusion MRI after Neoadjuvant radiotherapy for following tumor microenvironment [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gend, Belgium. |
| Henry, A., Nokin, M.-J., Leroi, N., LALLEMAND, F., Lambert, J., Goffart, N., Peixoto, P., Blomme, A., BIANCHI, E., Habraken, Y., RONCARATI, P., Peulen, O., SCHOLTES, F., MARTINIVE, P., Rogister, B., Delvenne, P., Turtoi, A., Castronovo, V., & Bellahcene, A. (22 March 2016). Osteopontin predicts radiotherapy response of glioblastoma patients : new role in DNA damage repair [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gand, Belgium. |
Leroi, N., BLACHER, S., Lallemand, F., Leenders, J., De Tullio, P., COUCKE, P., Noël, A., & MARTINIVE, P. (30 January 2016). Metabolomic analyzes of the tumor microenvironment after neoadjuvant radiotherapy implicated in surgery-related metastatic spreading [Paper presentation]. BACR, Bruxelles, Belgium. |
 | WITHOFS, N., Martinive, P., VANDERICK, J., BLETARD, N., SCAGNOL, I., Mievis, F., Giacomelli, F., Coucke, P., Delvenne, P., Cataldo, D., Gambhir, S. S., & HUSTINX, R. (2016). [18F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-015-3219-y Peer Reviewed verified by ORBi |
 | LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (2016). Diffusion MRI for following tumor modifications after neoadjuvant radiotherapy. Radiotherapy and Oncology, 119, 966-S967. Peer Reviewed verified by ORBi |
| Henry, A., Bellahcene, A., Castronovo, V., Peixoto, P., Goffart, N., Lallemand, F., Leroi, N., Peulen, O., MARTINIVE, P., Habraken, Y., Turtoi, A., Rogister, B., & Blomme, A. (Other coll.). (10 September 2015). Osteopontin as a new target in glioblastoma progression and resistance to radiotherapy [Paper presentation]. II International Symposium on clinical and basic investigation in glioblastoma, Toledo, Spain. |
 | LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (April 2015). Functional MRI for predicting metastatic spreading at the time of surgery after neoadjuvant radiotherapy. Radiotherapy and Oncology, 115 (Supplement 1), 832-S833. doi:10.1016/S0167-8140(15)41518-X Peer Reviewed verified by ORBi |
 | Vandaele, R., Marée, R., COUCKE, P., GULYBAN, A., LALLEMAND, F., Geurts, P., JODOGNE, S., & MARTINIVE, P. (April 2015). Automated Landmark Detection For Rigid Registration Between The Simulation-CT and the Treatment CBCT [Poster presentation]. 3rd ESTRO FORUM, Barcelone, Spain. |
| LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (27 January 2015). Identification of predictive markers based on functional imaging of metastatic spreading at the time of surgery after neoadjuvant radiotherapy [Poster presentation]. Giga day 2015, Liège, Belgium. |
 | VAN DAELE, D., Puleo, F., Dumont, R., POLUS, M., Loly, C., Martinive, P., Meunier, P., Collignon, J., Hendlisz, A., Marechal, R., Louis, E., & Van Laethem, J.-L. (2015). Evolution dans la prise en charge de l'adenocarcinome du pancreas localise estime resecable. Revue Médicale Suisse, 11 (483), 1543-8. Peer Reviewed verified by ORBi |
 | Leroi, N., Sounni, N. E., Van Overmeire, E., Blacher, S., Marée, R., Van Ginderachter, J., Lallemand, F., LENAERTS, E., COUCKE, P., Noël, A.* , & MARTINIVE, P.*. (2015). The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical model. Oncotarget. doi:10.18632/oncotarget.5931 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Goffart, N., KROONEN, J., Di Valentin, E., Dedobbeleer, M., Denne, A., Martinive, P., & Rogister, B. (2015). Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling. Neuro-Oncology, 17 (1), 81-94. doi:10.1093/neuonc/nou144 Peer Reviewed verified by ORBi |
 | VAN DAELE, D., Martinive, P., LOLY, C., POLUS, M., COLLIGNON, J., GAST, P., Louis, E., & Van Laethem, J.-L. (2015). COMMENT JE TRAITE ... Point de vue critique sur l'approche actuelle du cancer du pancreas localisé. Revue Médicale de Liège, 70 (11), 540-5. Peer reviewed |
 | Leroi, N., Blacher, S., Marée, R., Noël, A., COUCKE, P., & MARTINIVE, P. (29 June 2014). Does neoadjuvant radiotherapy and the timing of surgery modify metastatic dissemination? [Paper presentation]. 15th International Biennial Congress of the Metastasis Research Society, Heidelberg, Germany. |
 | MARTINIVE, P., ALLEPAERTS, S., VAN DAELE, D., POLUS, M., COIMBRA MARQUES, C., KOHNEN, L., COLLIGNON, J., LENNERTS, E., VANDERICK, J., & COUCKE, P. (2014). LA RADIOTHÉRAPIE DANS LE CANCER DU RECTUM CHEZ LA PERSONNE ÂGÉE: Quel bénéfice pour le traitement ? Revue Médicale de Liège, 69 (Supp 1), 47-52. Peer reviewed |
 | COUCKE, P., & MARTINIVE, P. (2014). LA RADIOBIOLOGIE POUR LES NÉOPHYTES. Revue Médicale de Liège, 69 (Supp 1), 16-19. Peer reviewed |
Leroi, N., Blacher, S., Marée, R., Noël, A., COUCKE, P., & MARTINIVE, P. (2014). Influence of tumor inflammatory microenvironment after neoadjuvant radiotherapy on lung metastases occurrence in a mouse model [Paper presentation]. BACR, Gand, Belgium. |
 | WITHOFS, N., BERNARD, C., VAN DER REST, C., MARTINIVE, P., HATT, M., JODOGNE, S., VISVIKIS, D., LEE, J. A., COUCKE, P., & HUSTINX, R. (2014). FDG PET/CT for rectal carcinoma radiotherapy treatment planning : Comparison of functional volume delineation algorithms and clinical challenges. Journal of Applied Clinical Medical Physics, 15 (5), 216-228. doi:10.1120/jacmp.v15i5.4696 Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LAKOSI, F., HUSTINX, R., WITHOFS, N., MEUNIER, P., TSHIBANDA, L., JODOGNE, S., COUCKE, P., & MARTINIVE, P. (2014). Utilisation de l'imagerie fonctionnelle en radiothérapie. Revue Médicale de Liège, 69 (Supp 1), 20-28. Peer reviewed |
 | MARTINIVE, P., VAN DAELE, D., LENNERTS, E., ALLEPAERTS, S., POLUS, M., COIMBRA MARQUES, C., KOHNEN, L., VANDERICK, J., COLLIGNON, J., & COUCKE, P. (2014). LA RADIOTHÉRAPIE DANS LE CANCER DU RECTUM : quand, comment et pourquoi ? Revue Médicale de Liège, 69 (Supp 1), 37-46. Peer reviewed |
 | JODOGNE, S., SOBCZAK, S., DEVILLERS, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (April 2013). Orthanc - Lightweight, Scriptable DICOM Server for Medical Image Management in Radiotherapy. Radiotherapy and Oncology, 106 (2), 488. Peer Reviewed verified by ORBi |
 | Leroi, N., NOEL, A., COUCKE, P., & MARTINIVE, P. (2013). Optimizing the timing of surgery after neoadjuvant radiotherapy for decreasing tumor metastasis [Paper presentation]. BACR, Anvers, Belgium. |
 | Leroi, N., Noël, A., COUCKE, P., & MARTINIVE, P. (May 2012). Modeling neoadjuvant radiotherapy for improving treatments efficacy [Poster presentation]. ESTRO 31. |
 | Leroi, N., COUCKE, P., Noël, A., & MARTINIVE, P. (February 2012). Tailoring the timing of surgery based on the neoadjuvant radiotherapy schedule for decreasing tumor dissemination at the time of surgical procedure [Paper presentation]. International Conference on Transnational Research in Radiation Oncology, Genève, Switzerland. |
 | WITHOFS, N., MARTINIVE, P., SCAGNOL, I., THONON, D., Giacomelli, F., Mievis, F., COUCKE, P., CATALDO, D., Gambhir, S., & HUSTINX, R. (2012). Preliminary results of (18F)FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. Journal of Nuclear Medicine, 53 (SUPPL), 1703. Peer Reviewed verified by ORBi |
| WITHOFS, N., Bernard, C., VAN DER REST, C., MARTINIVE, P., HATT, M., Dimitris, V., COUCKE, P., & HUSTINX, R. (2011). FDG PET/CT for radiotherapy treatment planning. Comparison of functional volume delineation algorithms. Journal of Nuclear Medicine. Peer Reviewed verified by ORBi |
 | Leroi, N., boujouf, S., COUCKE, P., Noël, A., & MARTINIVE, P. (January 2011). does neoadjuvant radiotherapy promote tumor dissemination [Poster presentation]. BACR-ABEC-BVSK. |
 | JANVARY, Z. L., JANSEN, N., MARTINIVE, P., & COUCKE, P. (2011). New indications for radiotherapy: primary liver cancer and secondary liver oligometastases. Belgian Journal of Medical Oncology, 5 (1), 8-13. Peer Reviewed verified by ORBi |
 | JANVARY, Z. L., JANSEN, N., MATHOT, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (September 2010). EVALUATION OF THE AUTOMATIC IMAGE REGISTRATION FEATURES OF A KV CONE-BEAM CT IMAGING SYSTEM. Radiotherapy and Oncology, 96 (supp 1). Peer Reviewed verified by ORBi |
JANVARY, Z. L., JANSEN, N., MATHOT, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (September 2010). EVALUATION OF THE AUTOMATIC IMAGE REGISTRATION FEATURES OF A KV CONE-BEAM CT IMAGING SYSTEM [Poster presentation]. Congrès. |
 | JANVARY, Z. L., Broens, A., MARTINIVE, P., Vvavassis, P., Fieuw, J., LENAERTS, E., & COUCKE, P. (September 2010). 4DCT EVALUATION OF THE RESPIRATORY-RELATED MOVEMENT OF THE BREAST USING SURGICAL CLIPS AS FIDUCIALS [Poster presentation]. ESTRO. |
 | Daneau, G., Boidot, R., MARTINIVE, P., & Feron, O. (15 January 2010). Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases. Clinical Cancer Research, 16 (2), 410-419. doi:10.1158/1078-0432.CCR-09-0583 Peer Reviewed verified by ORBi |
 | MARTINIVE, P., & COUCKE, P. (2010). La vascularisation tumorale en tant que source de résistance aux traitements de radiothérapie et chimiothérapie. Revue Médicale de Liège, 65 (3), 133-139. Peer reviewed |
 | Martinive, P. (2008). Impact of cyclic hypoxia on HIF-1a regulation in endothelial cells: new insights for anti-tumor treatments. FEBS Journal. doi:10.1111/j.1742-4658.2008.06798.x Peer Reviewed verified by ORBi |
 | Cron, G. O., Ansiaux, MARTINIVE, P., Feron, O., Gallez, B., & Beghein, N. (Other coll.). (2008). (19) F NMR in vivo spectroscopy reflects the effectiveness of perfusion - enhancing vascular modifiers for improving gemcitabine chemotheraypy. Magnetic Resonance in Medicine. doi:10.1002/mrm.21469 Peer Reviewed verified by ORBi |
 | Martinive, P. (2007). Impact of oxygen and blood flow heterogeneities in tumors : new insights for anti-cancer and anti-angiogenic therapies [Doctoral thesis, UCL - Université Catholique de Louvain]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/17876 |
 | Martinive, P. (January 2007). Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anti-cancer therapies [Poster presentation]. Meeting Gand, Gand, Belgium. |
 | Crokart, N., JORDAN, B., BAUDELET, C., CRON, G., HOTTON, J., RADERMACHER, K., GREGOIRE, V., BEGHIN, N., MARTINIVE, P., BOUZIN, C., FERON, O., & GALLEZ, B. (2007). Glucocorticoids Modulate Tumor Radiation Response through a Decrease in Tumor Oxygen Consumption. Clinical Cancer Research, 15 (13), 630/5. doi:10.1158/1078-0432.CCR-06-0802 Peer Reviewed verified by ORBi |
 | Martinive, P., DEFRESNE, F., BOUZIN, C., SALIEZ, J., LAIR, F., GREGOIRE, V., MICHIELS, C., DESSY, C., & FERON, O. (15 December 2006). Preconditioning of the Tumor Vasculature and Tumor Cells by Intermittent Hypoxia: Implications for Anticancer Therapies. Cancer Research, 66 (24), 11736-44. doi:10.1158/0008-5472.CAN-06-2056 Peer Reviewed verified by ORBi |
 | SEGERS, J., DI FAZIO, V., ANSIAUX, R., MARTINIVE, P., FERON, O., Wallemacq, P., & GALLEZ, B. (28 November 2006). Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: Importance of optimal scheduling to exploit the ‘normalization’ window of the tumor vasculature. Cancer Letters, 244 (1), 129/35. doi:10.1016/j.canlet.2005.12.017 Peer Reviewed verified by ORBi |
 | ANSIAUX, R., BAUDELET, C., JORDAN, B., CROKART, N., DEWEVER, J., MARTINIVE, P., GREGOIRE, V., FERON, O., & GALLEZ. (01 October 2006). Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy. Cancer Research, 66 (19), 9698/704. doi:10.1158/0008-5472.CAN-06-1854 Peer Reviewed verified by ORBi |
 | Martinive, P., DE WEVER, J., BOUZIN, C., BAUDELET, C., ONVEAUX, P., GREGOIRE, V., & FERON, O. (June 2006). Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery. Molecular Cancer Therapeutics, 5 (6), 1620/7. doi:10.1158/1535-7163.MCT-05-0472 Peer Reviewed verified by ORBi |
 | SBAA, E., DE WEVER, J., MARTINIVE, P., BOUZIN, C., FRERART, F., BALLIGAND, J.-L., DESSY, C., & FERON, O. (12 May 2006). Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circulation Research, 98 (9), 1219/27. doi:10.1161/01.RES.0000220648.80170.8b Peer Reviewed verified by ORBi |
 | Ansiaux, R., Baudelet, C., Cron, MARTINIVE, P., DEWEVER, J., GREGOIRE, V., FERON, O., & Gallez. (May 2006). Evolution of the tumor oxygenation and perfusion at the early stage of the treatment with SU5416, an inhibitor of Flk-1 tyrosine kinase [Poster presentation]. Proc. Intl. Soc. Mag. Reson. Med. |
 | Martinive, P. (2006). Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable parameter to improve drug delivrery [Paper presentation]. Meeting Brussels, Bruxelles, Belgium. |
 | ANSIAUX, R., BAUDELET, C., CRON, G., SEGERS, J., DESSY, C., Martinive, P., DE WEVER, J., VERRAX, J., WAUTHIER, V., BEGHEIN, N., GREGOIRE, V., BUC CALDERON, P., FERON, O., & GALLEZ, B. (15 February 2006). Botulinum toxin potentiates cancer radiotherapy and chemotherapy. Clinical Cancer Research, 12 (4), 1276/83. doi:10.1158/1078-0432.CCR-05-1222 Peer Reviewed verified by ORBi |
 | Brouet, A., DeWever, J., MARTINIVE, P., Havaux, X., Bouzin, C., Sonveaux, P., Feron, O., & Martinive, P. (Other coll.). (2005). Anti-tumor effect of caveolin gene delivery are mediated through the inhibition of the pro-angiogenic and vasodilatating effect of nitric oxide. FASEB Journal, 602-4. Peer Reviewed verified by ORBi |
 | ANSIAUX, R., BAUDELET, C., JORDAN, B., BEGHEIN, N., SONVEAUX, P., DE WEVER, J., MARTINIVE, P., GREGOIRE, V., FERON, O., & Gallez, B. (15 January 2005). Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clinical Cancer Research, 15 (11), 743-750. Peer Reviewed verified by ORBi |
 | Crokart, Jordan, Baudelet, C., Cron, Hotton, Radermacher, GREGOIRE, V., Beghein, MARTINIVE, P., FERON, O., & Gallez. (26 November 2004). Characterization of the tumor micro-environment after administration of glucocorticoids to understand their radiosensitization effect [Poster presentation]. 3rd one day symposium. |
 | Martinive, P., Sonveaux, P., Brouet, A., & Feron, O. (September 2004). Intrinsic and irradiation-induced tumor selectivity of liposome-based gene therapy targeting Akt activation [Poster presentation]. Experimental and Molecular Therapeutics. |
 | Martinive, P., Sonveaux, P., DeWever, J., Batova, Z., Daneau, G., Pelat, M., Ghisdal, P., Grégoire, V., Dessy, C., Balligand, J.-L., & Feron, O. (2004). caveolin-1 expression is critical for VEGF-induced inschemic hindlimb collateralization and NO-mediated angiogenisis. Circulation Research, (95 (2)), 154-61. Peer Reviewed verified by ORBi |
 | Sonveaux, P., Dessy, MARTINIVE, P., Havaux, X., Jordan, B., Gallez, B., Gregoire, V., Balligand, J.-L., & Feron, O. (May 2004). Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Research, 1 (64), 3209-14. doi:10.1158/0008-5472.CAN-03-1291 Peer Reviewed verified by ORBi |
Martinive, P. (January 2004). Targeting the vascular tone of microarterioles with an endothelin-1 (ET-1) antagonist selectively modulates tumor blood flow and promotes response to treatment [Poster presentation]. BACR, Liège, Belgium. |
Martinive, P. (2003). Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable parameter to improve drug delivery [Poster presentation]. American Association for Cancer Research (AACR), 97th Annual Meeting, Washington DC, United States. |